Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

Yes that's true but Cosmecueticals don't require FDA approval, and it depends how much better their product is compared to all other hyperpigmentation cosmetic products.

What I like about scarring is that if Rxi gets that approved first, it will become the first drug to be approved by the FDA for Scarring. Meaning no competition whatsoever, because Rxi can make the therapeutic claim to doctors that it has been approved by the FDA. There are other scar products on the market, but they can't make any FDA approval claims. They also don't work as well as RXI-109 IMO.

But I see your point cosmecueticals is very huge opportunity for RXII. The best part is that Dr. Geert mentioned on the call that once they are done with consumer testing, which could take up to 6 months from when they start, they have interested parties in partnering.